Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T16:11:00.656Z Has data issue: false hasContentIssue false

Schizophrenia and Respiratory Symptoms: A Serious, but Overlooked, Comorbidity

Published online by Cambridge University Press:  07 November 2014

Extract

Mr. A is 24 years of age with a history of schizophrenia (Slide 1). He has been living with his parents and has been ill for a few years. Police saw him on the street in a state of crisis and brought him to the emergency room (ER). He was very anxious and his delusions of being in great physical danger had worsened. He reported a history of asthma, but it was noted that his asthma occurred a long time ago and was inactive; however, due to his anxiety, his smoking had increased to where it was continuous. At the time he was brought to the ER, Mr. A was triaged to psychiatry and became agitated in the waiting area; hence, security was called. He was about to be restrained and given an intramuscular dose (IM) of lorazepam, but the psychiatrist noted that he was having trouble breathing and stopped the IM before it was given. The psychiatrist noticed that Mr. A was wheezing, had a rapid respiratory rate of 25/minute, was tachycardic, and sweating. His pulse oximeter measurement was 90% saturated, which is considered low.

Mr. A was re-interviewed and reported that he previously had asthma. His parents were contacted and agreed that he had active asthma, had stopped his psychiatric treatment several months ago, and, more recently, stopped his asthma medications when his prescriptions were not refilled ∼1 week prior to this episode. An emergency arterial blood gas showed a pH of acidosis at 7.27; a Po2 of 60 (normal is 80); and a Pco2 of 48 (normal is 40). The Pco2 was of particular concern because if he was retaining CO2, respiratory failure was imminent.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Samele, C, Patel, M, Boydell, J et al. , Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol. 2007;42(2):117124.CrossRefGoogle ScholarPubMed
2.Sokal, J, Messias, E, Dickerson, FB et al. , Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192(6):421427.CrossRefGoogle ScholarPubMed
3.Joseph, KS, Blais, L, Ernst, P, Suissa, S. Increased morbidity and mortality related to asthma amonth asthmatic patients who use major tranquilisers. BMJ. 1996;312:79081.CrossRefGoogle Scholar
4.Perna, G, Bertani, A, Politi, E, Colombo, G, Bellodi, L. Asthma and panic attacks. Biol Psychiatry. 1997;42:625630.CrossRefGoogle ScholarPubMed
5.Jones, A. Increased mortality related to asthma among asthmatic patients using major tranquillisers. Underlying ill health is the main risk factor. Br Med J. 1996;312:976.CrossRefGoogle ScholarPubMed
6.Joseph, KS, Blais, L, Ernst, P, Suissa, S. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. Br Med J. 1996;312:7982.CrossRefGoogle ScholarPubMed
7.Chiang, E, Pitts, Wm Jr, Rodriguez-Garcia, M. Respiratory dyskinesia: Review and case reports. J Clin Psychiatry. 1985;46:232234.Google ScholarPubMed
8.Flaherty, J, Lahmeyer, H. Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment. Am J Psychiatry. 1978;135:14141415.Google ScholarPubMed
9.Craig, TJ. Medication use and deaths attributed to asphyxia among psychiatric patients. Am J Psychiatry. 1980;137:13661373.Google ScholarPubMed
10.Barach, E, Dubin, LM, Tomlanovich, MC, Kottamasu, S. Dystonia presenting as upper airway obstruction. J Emerg Med. 1989;7:237240.CrossRefGoogle ScholarPubMed
11.Wilcox, PG, Bassett, A, Jones, B, Fleetham, JA. Respiratory dysrhythmias in patients with tardive dyskinesia. Chest. 1994;105:203207.CrossRefGoogle ScholarPubMed
12.Kruk, J, Sachdev, P. Neuroleptic-induced respiratory dyskinesia. J Neuropsychiatry Clin Neurosci. 1995;7:223229.Google ScholarPubMed
13.Weiden, PJ, Mann, JJ, Hass, G et al. , Clinical recognition of neuroleptic-induced movement disorders: a cautionary study. Am J Psychiatry. 1987;144:11481153.Google ScholarPubMed